Recently emerged omicron subvariant BF.7 and its R346T mutation in the RBD region reveal increased transmissibility and higher resistance to neutralization antibodies: need to understand more under the current scenario of rising cases in China and fears of driving a new wave of the COVID-19 pandemic-Reference-Cited by-同舟云学术

Recently emerged omicron subvariant BF.7 and its R346T mutation in the RBD region reveal increased transmissibility and higher resistance to neutralization antibodies: need to understand more under the current scenario of rising cases in China and fears of driving a new wave of the COVID-19 pandemic

Published:2023-03-14 Issue:4 Volume:109 Page:1037-1040
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Chakraborty Chiranjib¹,Bhattacharya Manojit²,Chopra Hitesh³^ORCID,Bhattacharya Prosun⁴,Islam Md. Aminul⁵⁶^ORCID,Dhama Kuldeep⁷^ORCID

Affiliation:

1. Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal

2. Department of Zoology, Fakir Mohan University, VyasaVihar, Balasore, Odisha

3. Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab

4. COVID-19 Research, Department of Sustainable Development, Environmental Science and Engineering, KTH Royal Institute of Technology, Stockholm, Sweden

5. COVID-19 Diagnostic Lab, Department of Microbiology, Noakhali Science and Technology University, Noakhali

6. Advanced Molecular Lab, Department of Microbiology, President Abdul Hamid Medical College, Karimganj, Kishoreganj, Bangladesh

7. Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference16 articles.

1. The rapid emergence of multiple sublineages of Omicron (B.1.1.529) variant: dynamic profiling via molecular phylogenetics and mutational landscape studies;Chakraborty;J Infect Public Health,2022

2. Omicron: increased transmissibility and decreased pathogenicity;Balint;Signal Transduct Target Ther,2022

3. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant;Suzuki;Nature,2022

4. Cases of BA.2.75 and recent BA.2.75.2 subvariant of Omicron are increasing in India: is it alarming at the global level?;Chakraborty;Ann Med Surg (Lond),2022

5. The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic – correspondence;Mohapatra;Int J Surg,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao;Vaccines;2024-08-21

2. Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection;Journal of Infection and Chemotherapy;2024-08

3. A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety;Infectious Medicine;2023-12

4. Impact of New COVID-19 Variant on Stroke, Thrombosis and Neurological Impairment;New COVID-19 Variants [Working Title];2023-11-23

5. Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China;Emerging Microbes & Infections;2023-11-16